Peptide Receptor Radionuclide Treatment and (131)I‐MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas - Concepedia

Concepedia

Publication | Closed Access

Peptide Receptor Radionuclide Treatment and (131)I‐MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas

78

Citations

16

References

2017

Year

Constantinos Nastos, Vincent Cheung, Christos Toumpanakis, Shaunak Navalkissoor, Anne‐Marie Quigley, Martyn Caplin, Bernard Khoo

Journal of Surgical Oncology

Abstract

PRRT treatment offers increased OS, PFS, EFS, and response to treatment compared to (131)I-MIBG therapy in patients with progressive/malignant PGLs.

References

	Year	Citations

Page 1